Understanding Our Medium Term Notes Join us to unlock exclusive insights, deepen your knowledge in the world of precious metals, and stay informed about our unique offerings
Food and Drug Administration (FDA) has recently proposed a significant regulatory shift that could reshape the compounding pharmacy and pharmaceutical manufacturing landscape
Yes, and the evidence is practical, not theoretical
doi: 10.1016/j.jointm.2023.02.002 Wu L, Xiong X, Wu X, et al
MAOIs (such as phenelzine) are rarely prescribed but require careful dietary and medication management
Drug companies are pricing diabetes medicines at almost 400 times the level necessary to make a profit, according to a new study